DAM Capital Advisors IPO: A gateway to India's capital market boom
DAM Capital Advisors IPO: A gateway to India's capital market boom

DAM Capital Advisors IPO: A gateway to India's capital market boom

From FY22 to FY24, the company achieved a Compound Annual Growth Rate (CAGR) of around 39 per cent in revenue and around 80 per cent in net profit.

DSIJ Intelligence Article rating: 5.0

From FY22 to FY24, the company achieved a Compound Annual Growth Rate (CAGR) of around 39 per cent in revenue and around 80 per cent in net profit.

Mamata Machinery IPO: Balanced risk and reward for investors
Mamata Machinery IPO: Balanced risk and reward for investors

Mamata Machinery IPO: Balanced risk and reward for investors

Over the period from FY22 to FY24, the company achieved a Compound Annual Growth Rate (CAGR) of around 10 per cent in revenue and 29 per cent in net profit.

DSIJ Intelligence Article rating: 4.5

Over the period from FY22 to FY24, the company achieved a Compound Annual Growth Rate (CAGR) of around 10 per cent in revenue and 29 per cent in net profit.

Want to invest in the future of diamonds? Don’t miss this IPO of a 65 per cent global market leader!
Want to invest in the future of diamonds? Don’t miss this IPO of a 65 per cent global market leader!

Want to invest in the future of diamonds? Don’t miss this IPO of a 65 per cent global market leader!

Between CY21 and CY23, the company achieved a CAGR of 32 per cent in revenue and 37 per cent in net profit, with an impressive CY23 RoE of 77 per cent and RoCE of 81 per cent.

DSIJ Intelligence Article rating: 4.2

Between CY21 and CY23, the company achieved a CAGR of 32 per cent in revenue and 37 per cent in net profit, with an impressive CY23 RoE of 77 per cent and RoCE of 81 per cent.

Market cheers for Rekha Jhunjhunwala-backed IPO: Is it a winning bet?
Market cheers for Rekha Jhunjhunwala-backed IPO: Is it a winning bet?

Market cheers for Rekha Jhunjhunwala-backed IPO: Is it a winning bet?

Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of around 54 per cent in revenue and 26 per cent in net profit.  

DSIJ Intelligence Article rating: 5.0

Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of around 54 per cent in revenue and 26 per cent in net profit.  

Can Sai Life Sciences ride the global CRDMO wave? A detailed IPO analysis
Can Sai Life Sciences ride the global CRDMO wave? A detailed IPO analysis

Can Sai Life Sciences ride the global CRDMO wave? A detailed IPO analysis

Sai Life Sciences Ltd, a prominent player in the CRDMO sector, is set to launch its IPO. Dive into the details of this ambitious offering, its financials, valuation, and whether it’s a wise investment for today’s market.

DSIJ Intelligence Article rating: 4.8

Sai Life Sciences Ltd, a prominent player in the CRDMO sector, is set to launch its IPO. Dive into the details of this ambitious offering, its financials, valuation, and whether it’s a wise investment for today’s market.

MobiKwik IPO creates buzz with 49 per cent GMP: Is it worth investing?
MobiKwik IPO creates buzz with 49 per cent GMP: Is it worth investing?

MobiKwik IPO creates buzz with 49 per cent GMP: Is it worth investing?

In this analysis, we take a closer look at One Mobikwik Systems Ltd and present you with the exclusive IPO details.

DSIJ Intelligence Article rating: 5.0

In this analysis, we take a closer look at One Mobikwik Systems Ltd and present you with the exclusive IPO details.

Mega Mart IPO: What investors need to know about its market entry
Mega Mart IPO: What investors need to know about its market entry

Mega Mart IPO: What investors need to know about its market entry

In this analysis, we take a closer look at Vishal Mega Mart Ltd and present you with the exclusive IPO details.

DSIJ Intelligence Article rating: 5.0

In this analysis, we take a closer look at Vishal Mega Mart Ltd and present you with the exclusive IPO details.

Is Suraksha Diagnostic Ltd IPO worth subscribing to?
Is Suraksha Diagnostic Ltd IPO worth subscribing to?

Is Suraksha Diagnostic Ltd IPO worth subscribing to?

In this analysis, we take a closer look at Suraksha Diagnostic Ltd and present you with the exclusive IPO details.

DSIJ Intelligence Article rating: 4.8

In this analysis, we take a closer look at Suraksha Diagnostic Ltd and present you with the exclusive IPO details.

Notable listing gains predicted for this IPO: Is it worth investing in?
Notable listing gains predicted for this IPO: Is it worth investing in?

Notable listing gains predicted for this IPO: Is it worth investing in?

Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of 80 per cent in revenue and 76 per cent in net profit.

DSIJ Intelligence Article rating: 5.0

Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of 80 per cent in revenue and 76 per cent in net profit.

RSS
123578910Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR